Cargando…

One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening

[Image: see text] The enzyme pteridine reductase 1 (PTR1) is a potential target for new compounds to treat human African trypanosomiasis. A virtual screening campaign for fragments inhibiting PTR1 was carried out. Two novel chemical series were identified containing aminobenzothiazole and aminobenzi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mpamhanga, Chidochangu P., Spinks, Daniel, Tulloch, Lindsay B., Shanks, Emma J., Robinson, David A., Collie, Iain T., Fairlamb, Alan H., Wyatt, Paul G., Frearson, Julie A., Hunter, William N., Gilbert, Ian H., Brenk, Ruth
Formato:	Texto
Lenguaje:	English
Publicado:	American Chemical Society 2009
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966039/ https://www.ncbi.nlm.nih.gov/pubmed/19527033 http://dx.doi.org/10.1021/jm900414x

Ejemplares similares

Design, Synthesis and Biological Evaluation of Novel Inhibitors of Trypanosoma brucei Pteridine Reductase 1
por: Spinks, Daniel, et al.
Publicado: (2011)

Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase
por: Shanks, Emma J., et al.
Publicado: (2010)

Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate
por: Dawson, Alice, et al.
Publicado: (2006)

Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice
por: Sienkiewicz, Natasha, et al.
Publicado: (2010)

Dissecting the Metabolic Roles of Pteridine Reductase 1 in Trypanosoma brucei and Leishmania major
por: Ong, Han B., et al.
Publicado: (2011)

Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei
por: Spinks, Daniel, et al.
Publicado: (2009)

Structure of recombinant Leishmania donovani pteridine reductase reveals a disordered active site
por: Barrack, Keri L., et al.
Publicado: (2010)

HTS and hit finding in academia – from chemical genomics to drug discovery
por: Frearson, Julie A., et al.
Publicado: (2009)

Structure-Based Design of Pteridine Reductase Inhibitors Targeting African Sleeping Sickness and the Leishmaniases
por: Tulloch, Lindsay B., et al.
Publicado: (2009)

Synthesis and Evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) Analogues as Inhibitors of Trypanothione Reductase
por: Patterson, Stephen, et al.
Publicado: (2009)

Optimisation of the Anti-Trypanosoma brucei Activity of the Opioid Agonist U50488
por: Smith, Victoria C, et al.
Publicado: (2011)

Structure-Based Design and Synthesis of Antiparasitic Pyrrolopyrimidines Targeting Pteridine Reductase 1
por: Khalaf, Abedawn I., et al.
Publicado: (2014)

Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum
por: Bhattacharya, Arijit, et al.
Publicado: (2021)

Identification of Inhibitors of the Leishmania cdc2-Related Protein Kinase CRK3
por: Cleghorn, Laura A T, et al.
Publicado: (2011)

Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography
por: Patterson, Stephen, et al.
Publicado: (2011)

Application of a simple quantum chemical approach to ligand fragment scoring for Trypanosoma brucei pteridine reductase 1 inhibition
por: Jedwabny, Wiktoria, et al.
Publicado: (2017)

Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Trypanosoma brucei Pteridine Reductase and Dihydrofolate Reductase
por: Tassone, Giusy, et al.
Publicado: (2021)

Identification of Kaurane-Type Diterpenes as Inhibitors of Leishmania Pteridine Reductase I
por: Herrera-Acevedo, Chonny, et al.
Publicado: (2021)

Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases
por: Santucci, Matteo, et al.
Publicado: (2021)

Sesquiterpene Lactones with Dual Inhibitory Activity against the Trypanosoma brucei Pteridine Reductase 1 and Dihydrofolate Reductase
por: Possart, Katharina, et al.
Publicado: (2021)

Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery
por: Linciano, Pasquale, et al.
Publicado: (2017)

In Silico and In Vitro Search for Dual Inhibitors of the Trypanosoma brucei and Leishmania major Pteridine Reductase 1 and Dihydrofolate Reductase
por: Possart, Katharina, et al.
Publicado: (2023)

In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I
por: Herrmann, Fabian C., et al.
Publicado: (2017)

Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity
por: Di Pisa, Flavio, et al.
Publicado: (2017)

Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1
por: Pöhner, Ina, et al.
Publicado: (2022)

Structure and dynamics of pteridine reductase 1: the key phenomena relevant to enzyme function and drug design
por: Panecka-Hofman, Joanna, et al.
Publicado: (2023)

Gene Regulation of Pteridine Reductase 1 in Leishmania Promastigotes and Amastigotes Using a Full-Length Antisense Construct
por: Kheirandish, F, et al.
Publicado: (2013)

Dual and selective inhibitors of pteridine reductase 1 (PTR1) and dihydrofolate reductase-thymidylate synthase (DHFR-TS) from Leishmania chagasi
por: Teixeira, Bárbara Velame Ferreira, et al.
Publicado: (2019)

Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors
por: Spinks, Daniel, et al.
Publicado: (2012)

To Hit or Not to Hit, That Is the Question – Genome-wide Structure-Based Druggability Predictions for Pseudomonas aeruginosa Proteins
por: Sarkar, Aurijit, et al.
Publicado: (2015)

Crystal structure of the ternary complex of Leishmania major pteridine reductase 1 with the cofactor NADP(+)/NADPH and the substrate folic acid
por: Dello Iacono, Lucia, et al.
Publicado: (2022)

Quinol derivatives as potential trypanocidal agents
por: Capes, Amy, et al.
Publicado: (2012)

Chemical Validation of Trypanothione Synthetase: A POTENTIAL DRUG TARGET FOR HUMAN TRYPANOSOMIASIS
por: Torrie, Leah S., et al.
Publicado: (2009)

Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode
por: Spinks, Daniel, et al.
Publicado: (2015)

Identification and structure solution of fragment hits against kinetoplastid N-myristoyltransferase
por: Robinson, David A., et al.
Publicado: (2015)

Identification of Novel Potential Inhibitors of Pteridine Reductase 1 in Trypanosoma brucei via Computational Structure-Based Approaches and in Vitro Inhibition Assays
por: Kimuda, Magambo Phillip, et al.
Publicado: (2019)

N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness
por: Frearson, Julie A., et al.
Publicado: (2010)

Pteridines and cytokines induce apoptotic cell death in alveolar epithelial cells
por: Schobersberger, W, et al.
Publicado: (1997)

An orally effective dihydropyrimidone (DHPM) analogue induces apoptosis-like cell death in clinical isolates of Leishmania donovani overexpressing pteridine reductase 1
por: Singh, Neeloo, et al.
Publicado: (2009)

Screening a protein kinase inhibitor library against Plasmodium falciparum
por: Hallyburton, Irene, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_un7llga3ml7q8h2iumu3dqktp6